If you take simvastatin to control cholesterol, watch out for infection says new report

Mar 01, 2010

Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.

"Statins are key drugs in the primary and secondary prevention of cardiovascular disease," said Cosima T. Baldari, Ph.D., a scientist from the Department of Evolutionary Biology at the University of Siena in Siena, Italy, who was involved in the research. "Our understanding of how these drugs affect the immune system should help maximize the benefits of these excellent drugs."

To make this discovery, the researchers conducted experiments using human cells and then followed up by conducting additional experiments in mice. They used human macrophages derived from blood samples of healthy donors and murine (mouse) macrophages. The macrophages were incubated with Staphlococcus aureus, a pathogen commonly found on the skin and in the upper airways. Once the infection manifested, researchers analyzed the bactericidal response of macrophages treated with simvastatin.

Results showed that the treated were significantly impaired in both the removal of the pathogen and related cell debris and the killing of ingested bacteria compared to untreated cells. Additionally, the treated cells produced higher amounts of cytokines, which are responsible for triggering and sustaining inflammation. The same experiment was conducted in vivo, using mouse models, with similar results.

"Statins are lifesavers, but there might be room for improvement," said John Wherry, Ph.D., Deputy Editor of the . "Studies like this help pave the way for researchers to develop newer versions of drugs like that are more specific for their intended effect increasing the benefits of these pharmaceuticals."

Explore further: B and T cell-targeting drug ameliorates chronic graft-versus-host disease in mice

More information: http://www.jleukbio.org.

add to favorites email to friend print save as pdf

Related Stories

Study Finds Chemical in Curry May Help Clear Plaques

Oct 03, 2006

UCLA/VA researchers found that curcumin - a chemical found in curry and turmeric - may help the immune system clear the brain of amyloid beta, which form the plaques found in Alzheimer's disease.

Recommended for you

Scientists aim to give botox a safer facelift

17 hours ago

New insights into botulinum neurotoxins and their interactions with cells are moving scientists ever closer to safer forms of Botox and a better understanding of the dangerous disease known as botulism. By comparing all known ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
1 / 5 (1) Mar 01, 2010
May this explains why there is no improvement in overall mortality for long term statin takers.